Smoking Cessation And Nicotine De-addiction Market Report

Smoking Cessation And Nicotine De-addiction Market Analysis By Product (Nicotine Replacement Therapy, Inhalers, Gums, Patches, Lozenges, Sprays, Sublingual Tablets, Varenicline, Bupropione, Drug therapy, E-cigarettes) And Segment Forecasts To 2024

  • Report ID: 978-1-68038-908-1
  • Number of Pages: 70
  • Format: Electronic (PDF)

Table of Content

Chapter 1. Methodology and Scope
                       1.1. Research Methodology
                       1.2. Research Scope & Assumptions
                       1.3. List of Data Sources
Chapter 2. Executive Summary
                       2.1. Smoking Cessation and Nicotine De-addiction Market- Industry Snapshot and Key Buying Criteria, 2015
Chapter 3. Smoking Cessation and Nicotine De-addiction Industry Outlook
                       3.1. Smoking Cessation and Nicotine De-addiction Market Segmentation
                       3.2. Smoking Cessation and Nicotine De-addiction Market Size and Growth Prospects
                       3.3. Smoking Cessation and Nicotine De-addiction Market Dynamics
                          3.3.1. Market Driver Analysis
                                3.3.1.1. Increasing demand for Nicotine De-addiction products
                                3.3.1.2. General awareness regarding the associated side-effects of smoking
                                3.3.1.3. Launch of new Nicotine De-addiction products
                          3.3.2. Market Restraint Analysis
                       3.4. Industry Analysis - Porter's
                       3.5. Smoking Cessation and Nicotine De-addiction Market PESTEL Analysis, 2015
Chapter 4. Smoking Cessation and Nicotine De-addiction Product Outlook
                       4.1. Smoking Cessation and Nicotine De-addiction Market Share By Product, 2015& 2024
                       4.2. Nicotine Replacement Market Estimates and Forecasts, 2013 - 2024 (USD Million)
                          4.2.1. Nicotine Sprays Market Estimates and Forecasts, 2013 - 2024 (USD Million)
                          4.2.2. Nicotine Inhalers Market Estimates and Forecasts, 2013 - 2024 (USD Million)
                          4.2.3. Nicotine Gums Market Estimates and Forecasts, 2013 - 2024 (USD Million)
                          4.2.4. Nicotine Transdermal Patches Market Estimates and Forecasts, 2013 - 2024 (USD Million)
                          4.2.5. Nicotine Sublingual Tablets Market Estimates and Forecasts, 2013 - 2024 (USD Million)
                          4.2.6. Nicotine Lozenges Market Estimates and Forecasts, 2013 - 2024 (USD Million)
                       4.3. Drug Therapy Market Estimates and Forecasts, 2013 - 2024 (USD Million)
                          4.3.1. Varenicline Oral Market Estimates and Forecasts, 2013 - 2024 (USD Million)
                          4.3.2. Zyban Oral Market Estimates and Forecasts, 2013 - 2024 (USD Million)
                          4.3.3. Nicorette Buccal Market Estimates and Forecasts, 2013 - 2024 (USD Million)
                       4.4. E-cigarettes/ E-liquid Market Estimates and Forecasts, 2013 - 2024 (USD Million)
Chapter 5. Smoking Cessation and Nicotine De-addiction Regional Outlook
                       5.1. Smoking Cessation and Nicotine De-addiction Market Share By Region, 2015 -2024
                       5.2. North America
                          5.2.1. North America Market Estimates and Forecasts, by Product, 2013 - 2024 (USD Million)
                                5.2.1.1. U.S. Market Estimates and Forecasts
                                5.2.1.2. Canada Market Estimates and Forecasts
                       5.3. Europe
                          5.3.1. Europe Market Estimates and Forecasts, by Product, 2013 - 2024 (USD Million)
                                5.3.1.1. Germany Market Estimates and Forecasts
                                5.3.1.2. UK Market Estimates and Forecasts
                       5.4. Asia Pacific
                          5.4.1. Asia Pacific Market Estimates and Forecasts, by Product, 2013 - 2024 (USD Million)
                                5.4.1.1. Japan Market Estimates and Forecasts
                                5.4.1.2. China Market Estimates and Forecasts
                       5.5. Latin America
                          5.5.1. Latin America Market Estimates and Forecasts, by Product, 2013 - 2024 (USD Million)
                                5.5.1.1. Brazil Market Estimates and Forecasts
                       5.6. MEA
                          5.6.1. MEA Market Estimates and Forecasts, by Product, 2013 - 2024 (USD Million)
                                5.6.1.1. South Africa Market Estimates and Forecasts
Chapter 6. Competitive Landscape
                       6.1. Pfizer, Inc.
                          6.1.1. Company Overview
                          6.1.2. Financial Performance
                          6.1.3. Product Benchmarking
                          6.1.4. Strategic Initiatives
                       6.2. GSK plc
                          6.2.1. Company Overview
                          6.2.2. Financial Performance
                          6.2.3. Product Benchmarking
                          6.2.4. Strategic Initiatives
                       6.3. Cipla Ltd.
                          6.3.1. Company Overview
                          6.3.2. Financial Performance
                          6.3.3. Product Benchmarking
                          6.3.4. Strategic Initiatives
                       6.4. Novartis International AG
                          6.4.1. Company Overview
                          6.4.2. Financial Performance
                          6.4.3. Product Benchmarking
                          6.4.4. Strategic Initiatives
                       6.5. McNeil AB
                          6.5.1. Company Overview
                          6.5.2. Financial Performance
                          6.5.3. Product Benchmarking
                          6.5.4. Strategic Initiatives
                       6.6. Revolymer plc
                          6.6.1. Company Overview
                          6.6.2. Financial Performance
                          6.6.3. Product Benchmarking
                          6.6.4. Strategic Initiatives
                       6.7. Takeda Pharmaceutical Company Ltd.
                          6.7.1. Company Overview
                          6.7.2. Financial Performance
                          6.7.3. Product Benchmarking
                          6.7.4. Strategic Initiatives
                       6.8. Imperial Tobacco Ltd.
                          6.8.1. Company Overview
                          6.8.2. Financial Performance
                          6.8.3. Product Benchmarking
                          6.8.4. Strategic Initiatives
                       6.9. VMR Products, LLC
                          6.9.1. Company Overview
                          6.9.2. Financial Performance
                          6.9.3. Product Benchmarking
                          6.9.4. Strategic Initiatives


List of Tables

TABLE 1 Smoking cessation and nicotine de-addiction market, - Industry Summary & Critical Success Factors (CSFs)
TABLE 2 Smoking cessation and nicotine de-addiction market, by product, 2013- 2024 (USD Million)
TABLE 3 Smoking cessation and nicotine de-addiction market, by region, 2013 - 2024 (USD Million)
TABLE 4 Smoking cessation and nicotine de-addiction market 2013 - 2024 (USD Million)
TABLE 5 Smoking cessation and nicotine de-addiction market- Key market driver analysis
TABLE 6 Smoking cessation and nicotine de-addiction market - Key market restraint analysis
TABLE 7 Nicotine replacement therapy product revenue,2013 - 2024 (USD Million)
TABLE 8 Nicotine spray revenue, 2013 - 2024 (USD Million)
TABLE 9 Nicotine inhalers revenue, 2013 - 2024 (USD Million)
TABLE 10 Nicotine gums revenue, 2013 - 2024, (USD Million)
TABLE 11 Nicotine transdermal patches revenue, 2013 - 2024 (USD Million)
TABLE 12 Nicotine sublingual tablets revenue, 2013 - 2024 (USD Million)
TABLE 13 Nicotine lozenges revenue, 2013 - 2024, (USD Million)
TABLE 14 Drug therapy revenue, 2013 - 2024, (USD Million)
TABLE 15 Vareniclinerevenue, 2013 - 2024, (USD Million)
TABLE 16 Zyban revenue, 2013 - 2024, (USD Million)
TABLE 17 Nicorette revenue, 2013 - 2024 (USD Million)
TABLE 18 E-cigarettes/E-liquid, 2013 - 2024 (USD Million)
TABLE 19 North America smoking cessation and nicotine de-addiction market, by product, 2013 - 2024 (USD Million)
TABLE 20 U.S smoking cessation and nicotine de-addiction market, by product, 2013 - 2024 (USD Million)
TABLE 21 Canada smoking cessation and nicotine de-addiction market, by product, 2013 - 2024 (USD Million)
TABLE 22 Europe smoking cessation and nicotine de-addiction market, by product, 2013 - 2024 (USD Million)
TABLE 23 Germany smoking cessation and nicotine de-addiction market, by product, 2013 - 2024 (USD Million)
TABLE 24 UK smoking cessation and nicotine de-addiction market, by product, 2013 - 2024 (USD Million)
TABLE 25 Asia Pacific smoking cessation and nicotine de-addiction market, by product, 2013 - 2024 (USD Million)
TABLE 26 Japan smoking cessation and nicotine de-addiction market, by product, 2013 - 2024 (USD Million)
TABLE 27 China smoking cessation and nicotine de-addiction market, by product, 2013 - 2024 (USD Million)
TABLE 28 Latin America smoking cessation and nicotine de-addiction market, by product, 2013 - 2024 (USD Million)
TABLE 29 Brazil smoking cessation and nicotine de-addiction market, by product, 2013 - 2024 (USD Million)
TABLE 30 MEA smoking cessation and nicotine de-addiction market, by product, 2013 - 2024 (USD Million)
TABLE 31 South Africa smoking cessation and nicotine de-addiction market, by product, 2013 - 2024 (USD Million)


List of Figures

FIG. 1 Smoking Cessation And Nicotine De-addiction market segmentation
FIG. 2 Smoking Cessation and Nicotine De-addiction Market Revenue, 2013 - 2024 (USD Million)
FIG. 3 Smoking Cessation and Nicotine De-addiction Market Dynamics
FIG. 4 Key Opportunities Prioritized
FIG. 5 Smoking Cessation and Nicotine De-addiction market- Porter’s Analysis
FIG. 6 Smoking Cessation and Nicotine De-addiction Market- PESTEL Analysis
FIG. 7 Smoking Cessation and Nicotine De-addiction Market Share by Product, 2013& 2024
FIG. 8 Smoking Cessation and Nicotine De-addiction Market Share by Country, 2013& 2024
FIG. 9 North America Smoking Cessation and Nicotine De-addiction Market, by Product, 2013 - 2024 (USD Million)
FIG. 10 U.S. Smoking Cessation and Nicotine De-addiction Market, by Product, 2013 - 2024 (USD Million)
FIG. 11 Canada Smoking Cessation and Nicotine De-addiction Market, by Product, 2013 - 2024 (USD Million)
FIG. 12 Europe Smoking Cessation and Nicotine De-addiction Market, by Product, 2013 - 2024 (USD Million)
FIG. 13 UK Smoking Cessation and Nicotine De-addiction Market, by Product, 2013 - 2024 (USD Million)
FIG. 14 Germany Smoking Cessation and Nicotine De-addiction Market, by Product, 2013 - 2024 (USD Million)
FIG. 15 Asia Pacific Smoking Cessation and Nicotine De-addiction Market, by Product, 2013 - 2024 (USD Million)
FIG. 16 China Smoking Cessation and Nicotine De-addiction Market, by Product, 2013 - 2024 (USD Million)
FIG. 17 Japan Smoking Cessation and Nicotine De-addiction Market, by Product, 2013 - 2024 (USD Million)
FIG. 18 Latin America Smoking Cessation and Nicotine De-addiction Market, by Product, 2013 - 2024 (USD Million)
FIG. 19 Brazil Smoking Cessation and Nicotine De-addiction market, by Product, 2013 - 2024 (USD Million)
FIG. 20 MEA Smoking Cessation and Nicotine De-addiction Market, by Product, 2013 - 2024 (USD Million)
FIG. 21 South Africa Smoking Cessation and Nicotine De-addiction Market, by Product, 2013 - 2024 (USD Million)

What questions do you have? Get quick response from our industry experts. Request a Free Consultation
pdf

GET A FREE SAMPLE

bck

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

cog

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

esomar icon

ESOMAR certified & member

D&B icon

Leading SME award by D&B

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.

great place to work icon